Business · 16/02/1999Updated: 10/17/2026 · 1 min read
FDA Extends Comment Period for Draft Guidance on Medical Imaging Drugs and Biologics
Summary
The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on developing medical imaging drugs and biologics until April 14, 1999, in response to industry requests.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →